MICHELLE REILY: Open Payments
NPI 1710311378 · WILLOW GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 17 payments from 11 companies in 2025. Trend: 2023 $68 · 2024 $728 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Pharmacosmos Therapeutics Inc. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Celgene Corporation | 1 | $26 |
| Exelixis Inc. | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| TerSera Therapeutics LLC | 1 | $17 |
Products named: CALQUENCE, MONOFERRIC, Enhertu, REBLOZYL, Vanflyta, CABOMETYX, ULTOMIRIS, ELREXFIO.
Industry payments across PA — which companies pay providers there.
